therapyipos

42 results found.

Top Stocks matching your search for "therapy ipos"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
BXRX

Baudax Bio Inc

-52.79%

$3.41 - $1.61

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Sep, 29, 2022

So undervalued cancer bio. πŸ‘

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
HTGM

HTG Molecular Diagnostics Inc

-37.26%

$4.67 - $2.93

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 3, 2023

So brilliant to save people’s lives and stop cancer in its tracks.

Jan, 13, 2023

$HTGM $THER Ther good buy with 1$ soon Ther... See more

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
SLS

SELLAS Life Sciences Group Inc

-63.99%

$3.61 - $1.30

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 20, 2023

These patients experienced about 35% longer surviv... See more

Mar, 20, 2023

* Best Available Therapy offers 6-8 months of Over... See more

BXRX

Baudax Bio Inc

-52.79%

$3.41 - $1.61

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Sep, 29, 2022

So undervalued cancer bio. πŸ‘

HTGM

HTG Molecular Diagnostics Inc

-37.26%

$4.67 - $2.93

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 3, 2023

So brilliant to save people’s lives and stop cancer in its tracks.

Jan, 13, 2023

$HTGM $THER Ther good buy with 1$ soon Theralink.com Tests available for cancers and rppa tech for treatments Ther stock symbol

Jan, 11, 2023

$HTGM best tests on the market for cancer

Dec, 27, 2022

Plus it is expecting more positive catalysts in weeks and months: 5 year data for breast cancer, Canada approval, China commercialziation, and much more.

Dec, 13, 2022

$PBLA cheapest cancer therapy stock on the market, load-up!!

Dec, 12, 2022

$HTGM MGTA BIG ONE POSITIVE GENE THERAPY

SLS

SELLAS Life Sciences Group Inc

-63.99%

$3.61 - $1.30

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 20, 2023

These patients experienced about 35% longer survival than has been reported for other second-line therapies.

Mar, 20, 2023

* Best Available Therapy offers 6-8 months of Overall Survival * All pooled Regal patients, BAT and Gps combined, is 16 months.

Mar, 17, 2023

* Best Available Therapy offers 6-8 months of Overall Survival * All pooled Regal patients, BAT and Gps combined, is 16 months.

Mar, 17, 2023

* Best Available Therapy offers 6-8 months of Overall Survival * All pooled Regal patients, BAT and Gps combined, is 16 months.

Mar, 13, 2023

Good cancer stock from what I hear in 2028.

Feb, 6, 2023

$MRK Ovarian cancer data final P2 results are better than any other drugs by a mile.

Feb, 3, 2023

They address a broad range of cancer indications.

Feb, 3, 2023

$SLS Gps arm 22 months of median Overall Survival Best Available Therapy 8.

Feb, 1, 2023

$SLS In addition to GPs FDA approval for AML secondary Remission patients - Gps + Keytruda/Checkpoint Inhibition is also best in class for Ovarian cancer patients.

Jan, 24, 2023

The nation’s best means the O'Neal Comprehensive Center in Alabama have access to the latest therapies, cutting-edge clinical trials and the expertise needed to treat their cancer.